Mesenchymal Stem Cell-Based Therapies against Podocyte Damage in Diabetic Nephropathy
Tissue Engineering and Regenerative Medicine
;
(6): 201-210, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-644035
ABSTRACT
Injury to podocytes is an early event in diabetic nephropathy leading to proteinuria with possible progression to end-stage renal failure. The podocytes are unique and highly specialized cells that cover the outer layer of kidney ultrafiltration barrier and play an important role in glomerular function. In the past few decades, adult stem cells, such as mesenchymal stem cells (MSCs) with a regenerative and differentiative capacity have been extensively used in cell-based therapies. In addition to their capability for regeneration and differentiation, MSCs contributes to their milieu by paracrine action of a series of growth factors via antiapoptotic, mitogenic and other cytokine actions that actively participate in treatment of podocyte damage through prevention of podocyte effacement, detachment and apoptosis. It is hoped that novel stem cell-based therapies will be developed in the future to prevent podocyte injury, thereby reducing the burden of kidney disease.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Proteinúria
/
Regeneração
/
Ultrafiltração
/
Apoptose
/
Peptídeos e Proteínas de Sinalização Intercelular
/
Nefropatias Diabéticas
/
Podócitos
/
Células-Tronco Adultas
/
Células-Tronco Mesenquimais
/
Esperança
Idioma:
Inglês
Revista:
Tissue Engineering and Regenerative Medicine
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS